An interventional study of Combined spinal-epidural anesthesia and General Anesthesia (GA) in Pregnancy and Neonatal Hearing Function, sponsored by Second Affiliated Hospital of Wenzhou Medical University. Recruiting at 1 site in China. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Second Affiliated Hospital of Wenzhou Medical University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a single-center, prospective, single-blind randomized controlled trial. The investigators plan to recruit 144 pregnant women scheduled for cesarean delivery. Participants will be randomly assigned to receive either combined spinal-epidural anesthesia (CSEA) or general anesthesia (GA). The study aims to compare the effects of these two anesthetic techniques on neonatal hearing after cesarean delivery. The investigators will collect neonatal transient evoked otoacoustic emission (TEOAE) screening results and conduct follow-up hearing assessments at 3-6 months of age for infants who fail repeat screening. The investigators will also record maternal intraoperative hemodynamic changes, the interval from anesthesia initiation to neonatal delivery, neonatal Apgar scores at 1 and 5 minutes, and maternal postoperative pain scores at multiple time points.
This is a single-center, prospective, single-blind, parallel-group randomized controlled trial. A total of 144 eligible parturients undergoing cesarean section will be enrolled and randomly allocated in a 1:1 ratio to the combined spinal-epidural anesthesia (CSEA) group or general anesthesia (GA) group. An independent statistician will generate the randomization sequence using a computerized random number table. Allocation concealment will be maintained using sealed, opaque, sequentially numbered envelopes, which will be opened by an independent coordinator after enrollment.
Participants will not be informed of their assigned anesthesia group. Anesthesia providers and surgical teams will be aware of group assignment. All outcome assessors, including personnel recording hemodynamic data, assessing Apgar scores, performing TEOAE hearing screening, and collecting postoperative VAS pain scores and adverse-event data, will remain blinded to group allocation to reduce assessment bias.
The investigators will compare maternal intraoperative hemodynamic changes and record the interval from anesthesia administration to neonatal delivery. Neonatal Apgar scores will be recorded at 1 and 5 minutes. Maternal postoperative Visual Analogue Scale (VAS) pain scores will be collected at 1, 6, 12, 24, and 48 hours after surgery. Neonatal hearing outcomes will include initial and repeat transient evoked otoacoustic emission (TEOAE) screening results. Infants who fail repeat screening will undergo further hearing assessment at 3-6 months of age to identify hearing loss.
Second Affiliated Hospital of Wenzhou Medical University is the lead sponsor of 137 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:(a) Singleton pregnancy with gestational age 37-42 weeks; (b) Maternal age 18-35 years; (c) (ASA) physical status II; (d) Scheduled for elective cesarean delivery based on clinical indications; (e) Written obtained from the parturient and her family.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive combined spinal-epidural anesthesia for elective cesarean section. Intraoperative hemodynamic parameters, time from anesthesia initiation to fetal delivery, neonatal Apgar scores, postoperative VAS pain scores and neonatal TEOAE hearing screening results will be collected.
Procedure: Combined spinal-epidural anesthesia
Participants receive general anesthesia for elective cesarean section. The same set of maternal and neonatal indicators will be collected and compared with the CSEA group.
Procedure: General Anesthesia (GA)
Combined spinal-epidural anesthesia is administered for elective cesarean section according to the study protocol
General anesthesia performed for cesarean delivery
1. Neonatal hearing screening pass rate by transient evoked otoacoustic emission (TEOAE)
The pass rate of neonatal transient evoked otoacoustic emission (TEOAE) hearing screening within 72 hours after birth.
Time frame: Within 72 hours after delivery
Maternal intraoperative hemodynamic changes
Changes in maternal blood pressure and heart rate during cesarean section.
Time frame: during surgery
Neonatal Apgar scores
Apgar scores will be assessed at 1 and 5 minutes after birth. The Apgar score evaluates five components: Appearance, Pulse, Grimace, Activity, and Respiration. The total score ranges from 0 to 10, with higher scores indicating better neonatal condition and a better outcome.
Time frame: 1 minute and 5 minutes after birth
Postoperative maternal VAS pain score
Postoperative maternal pain intensity will be assessed using the Visual Analog Scale (VAS) at 1, 6, 12, 24, and 48 hours after cesarean delivery. The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and therefore a worse outcome.
Time frame: 1 hour, 6 hours, 12 hours, 24 hours and 48 hours after surgery
Plan to share: Yes — Deidentified individual participant data including baseline characteristics, intraoperative variables, postoperative VAS pain scores, and neonatal hearing screening results will be shared.
Supporting information: Study protocol, Analytic code
No publications or documents are linked to this record.
Ran from Aug 2025 to primary completion in Jun 2026, 9 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital of Wenzhou Medical University →